Skip to main content

Forager Capital Management Proposes to Acquire Repay Holdings Corporation for $4.80 Per Share in Cash

Proposal Represents a 75% Premium to the 30-day VWAP of $2.75 BIRMINGHAM, Ala., April 17, 2026 (GLOBE NEWSWIRE) — Forager Capital Management, LLC, the largest shareholder of Repay Holdings Corporation (NASDAQ: RPAY) (the “Company”), with beneficial ownership of approximately 13% of the issued and outstanding shares, sent the below letter to the Board of Directors of the Company, which details its $4.80 per share, all-cash proposal to acquire the Company. April 17, 2026 Repay Holdings Corporation3060 Peachtree Road NW, Suite 1100Atlanta, Georgia 30305Attention: Board of Directors Dear Members of the Board, I am writing to you on behalf of Forager Capital Management, LLC (“Forager”). We have followed Repay Holdings Corporation (the “Company”) since its IPO, and we currently own approximately 13% of the issued and outstanding shares....

Continue reading

Private Bancorp of America, Inc. Announces Continued Strong Net Income for First Quarter 2026

First Quarter 2026 HighlightsNet income for the first quarter of 2026 was $12.0 million, compared to $10.0 million in the prior quarter and $10.6 million in the first quarter of 2025. Net income for the first quarter of 2026 represents a return on average assets of 1.88% and a return on average tangible common equity(1) of 18.07%. Diluted earnings per share for the first quarter of 2026 was $2.07, compared to $1.71 in the prior quarter and $1.80 in the first quarter of 2025. Core deposits were $2.33 billion as of March 31, 2026, an increase of $166.3 million or 7.7% from December 31, 2025, and an increase of $276.0 million or 13.5% from March 31, 2025. Total deposits were $2.37 billion as of March 31, 2026, an increase of $150.8 million or 6.8% from December 31, 2025, which included a reduction in brokered deposits of $15.5 million. Total...

Continue reading

SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson

EMJ Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between SRx Health Solutions and EMJX NORTH PALM BEACH, Fla., April 17, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today released a letter to shareholders providing an update on the proposed transaction from Eric. M. Jackson, the creator of the EMJX platform. Mr. Jackson will be appointed as an officer of the Company’s EMJC subsidiary following the merger. Dear Shareholders, I wanted to take this opportunity to provide an update on our latest progress and the merger agreement between...

Continue reading

Myseum.AI Accepted into Advanced Micro Devices AI Developer Program

Company featured as a “Next Super Stock” by Wall Street Reporter  CEO Darin Myman discusses AI platform innovations, user growth, and Picture Party platform NEW BRUNSWICK, N.J., April 17, 2026 (GLOBE NEWSWIRE) — Myseum.AI, Inc. (Nasdaq: MYSE) (“Myseum.AI” or the “Company”), a privacy-first social media and technology innovator, today announced that it has been accepted into the AMD AI Developer Program by Advanced Micro Devices, facilitating access to AMD Developer Cloud credits, advanced tools, training and community resources designed to support and accelerate artificial intelligence development. The Company also announced that CEO Darin Myman was interviewed by the Wall Street Reporter in the “Next Super Stock” segment. The interview is available at wallstreetreporter.com. Darin Myman, CEO of Myseum.AI, commented, “Just days...

Continue reading

CTW Cayman to Hold Annual General Meeting on May 7, 2026: Shareholders to Vote on Corporate Name Change and Amended Articles

TOKYO, April 17, 2026 (GLOBE NEWSWIRE) — CTW Cayman (Nasdaq: CTW) (“CTW” or the “Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, today announced that it will hold an annual general meeting of shareholders (the “AGM”) on May 7, 2026 at 10:00 AM (Tokyo time) at ARK Hills Sengokuyama Mori Tower, 29F, 1-9-10, Roppongi, Minato City, Tokyo, Japan. At the AGM, shareholders will be asked to consider and vote on several proposals, including:  ●    Changing the Company’s corporate name to CTW to align with its global brand and Nasdaq ticker symbol     ●    Adopting the Company’s Second Amended and Restated Memorandum and Articles of Association     ●    Authorizing related actions to implement the above proposalsThe Board of Directors unanimously...

Continue reading

Auction result of Treasury Bonds – RIKS 29 0917 – RIKS 37 0115

Series  RIKS 29 0917 RIKS 37 0115Settlement Date  04/22/2026 04/22/2026Total Amount Allocated (MM)  4,456 5,857All Bids Awarded At (Price / Yield)  101.700 / 2.964 83.424 / 2.810Total Number of Bids Received  17 32Total Amount of All Bids Received (MM)  5,436 7,007Total Number of Successful Bids  10 27Number of Bids Allocated in Full  10 27Lowest Price / Highest Yield Allocated  101.700 / 2.964 83.424 / 2.810Highest Price / Lowest Yield Allocated  101.750 / 2.949 83.660 / 2.781Lowest Price / Highest Yield Allocated in Full  101.700 / 2.964 83.424 / 2.810Weighted Average of Successful Bids (Price/Yield)  101.703 / 2.963 83.553 / 2.794Best Bid (Price / Yield)  101.750 / 2.949 83.660 / 2.781Worst Bid (Price / Yield)  101.649 / 2.980 83.180 / 2.840Weighted Average of All Bids Received (Price / Yield)  101.696 / 2.965 83.499 / 2.801Percentage...

Continue reading

WEBUY GLOBAL LTD. Launches Exclusive Antarctica Expedition Cruise Under Premium Brand Altitude Travel, Achieves Over US$777,500 in First Month Total Transaction Value

Singapore, April 17, 2026 (GLOBE NEWSWIRE) — WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a technology-driven comprehensive travel solutions company, today announced the successful launch of its latest premium travel offering under Altitude Travel, the Company’s high-end travel brand, featuring an exclusive chartered Antarctica expedition cruise experience that generated over US$777,500 in total transaction value within its first month of launch. This launch supports the Company’s strategy to expand its premium, experience-led travel offerings targeting high-value customers. The Antarctica expedition offering represents a high-end expedition experience to one of the world’s most remote and iconic destinations, combining expedition cruising, curated itineraries, immersive exploration, and premium service standards...

Continue reading

PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing Companies

Approximately $10 Million To Be Funded at First Closing; 24-Month Commitment Period Provides Dedicated Capital to Execute on Active M&A Pipeline Currently focused on Aerospace, Defense, and Industrial Manufacturing NEWPORT BEACH, Calif., April 17, 2026 (GLOBE NEWSWIRE) — PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”), a diversified holding company executing a targeted roll-up strategy in U.S.-based precision manufacturing, today announced its entry into a $40 million equity purchase facility (the “Facility”) with an institutional investor. The initial tranche of approximately $10 million is expected to be funded at closing, anticipated today. The Company may draw additional amounts at its sole discretion over a 24-month commitment period and require the investor to purchase shares of common stock from the Company...

Continue reading

Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome

Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinoma PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced the submission of an Orphan Drug Designation (ODD) application to the U.S. Food and Drug Administration for SkinJect® (D-MNA) for the treatment of basal cell carcinoma (BCC) in patients with Gorlin Syndrome, a rare genetic disorder characterized by the development of multiple, recurrent skin cancers. The submission represents a strategic expansion of the SkinJect program into a high unmet need...

Continue reading

SAGA Metals Secures Maximum JEA Grant for Labrador and Adopts Semi-Annual Financial Reporting

VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discoveries, is pleased to report that it has been awarded $225,000 under the Junior Exploration Assistance (“JEA”) program, representing the maximum funding available for the 2025 program for exploration expenditures in Labrador. This funding supported the Company’s 2025 drilling program at its Radar Critical Minerals Project in Labrador. The JEA program provides non-dilutive funding to advance mineral exploration across Newfoundland and Labrador, with a focus on new discovery and development of projects toward defined mineral resources. About the Radar Critical Mineral Property in Labrador The Radar...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.